Funding Support and Author Disclosures Dr. Kosiborod has received grants, honoraria, and other research support from AstraZeneca; has received grants and honoraria from Boehringer Ingelheim; and has received honoraria from Sanofi, Amgen, NovoNordisk, Merck (Diabetes), Eisai, Janssen, Bayer, GlaxoSmithKline, Glytec, Intarcia, Novartis, Applied Therapeutics, Amarin, and Eli Lilly. Dr. Vaduganathan has received research grant support or served on advisory boards for American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Boehringer Ingelheim, Cytokinetics, and Relypsa; and participates on clinical endpoint committees for studies sponsored by Galmed, Novartis, and the National Institutes of Health.